Benzylsulfonyl-D-Arg-Pro-4-amdinobenzylamid (BAPA) is a potent synthetic anticoagulant which inhibits Factor Xa and thrombin.
A complex web of biochemical and physical reactions between platelets and clotting factors at the site of vascular injury is required to achieve hemostasis.
Under flow conditions, platelet activation and coagulation processes are dynamically intertwined with each other affected by platelets, coagulation factors and their various inhibitors and activators.